DEUTSCHE BANK AG\
BankPosition in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in AMLX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$17,622,210
+$1,516,721 QoQ
Shares Held
1,267,785
-4.9% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $1,164,451,125 across 44 Drug Manufacturers - Specialty & Generic names. AMLX ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,532,028 | $653,941,023 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
198,777 | $117,870,782 | |
| 3 | VTRS |
Viatris Inc
|
6,512,440 | $87,983,060 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,829,970 | $85,238,695 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
365,345 | $48,130,546 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
523,691 | $25,215,720 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
319,675 | $24,583,006 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
236,885 | $17,967,724 |
All Filings in AMLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,622,210 | 1,267,785 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $16,105,489 | 1,333,236 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $18,557,430 | 1,365,521 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,954,450 | 616,919 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,020,833 | 570,857 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,157,839 | 570,857 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,849,576 | 570,857 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $1,084,628 | 570,857 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $2,147,519 | 756,169 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $12,556,159 | 853,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $447,056 | 24,416 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $4,133,048 | 191,611 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $918,927 | 31,320 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $811,458 | 21,961 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $421,799 | 14,984 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $90,367 | 4,692 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $68,734 | 5,349 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||